FIELD: pharmaceutics.
SUBSTANCE: invention relates to organic chemistry, namely, to quinoline carboxamide derivatives of following structures. Invention also relates to pharmaceutical composition based on one of said compounds, use of said compounds for treating diseases or disorders mediated by mGluR2, such as Alzheimer's disease, cognitive disorder, schizophrenia, mood disorders, painful disorders, and sleep disorders.
EFFECT: novel quinoline carboxamide derivatives with useful biological properties.
25 cl, 8 tbl, 310 ex
Title | Year | Author | Number |
---|---|---|---|
PYRAZOLYL-SUBSTITUTED BENZENESULFONEAMIDE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT, METHOD OF TREATMENT OF PATIENTS WITH INFLAMMATION OR INFLAMMATION-ASSOCIATED DISEASES | 1994 |
|
RU2139281C1 |
CATECHOL-O-METHYL TRANSFERASE INHIBITORS AND USE THEREOF IN TREATING PSYCHOTIC DISORDERS | 2011 |
|
RU2586974C2 |
SUBSTITUTED HETEROCYCLIC SULPHONAMIDE COMPOUNDS USEFUL AS TRPA1 MODULATORS | 2014 |
|
RU2675792C2 |
NOVEL COMPOUNDS THAT ARE ERK INHIBITORS | 2013 |
|
RU2660429C2 |
METHOD FOR TREATING INFLAMMATION OR INFLAMMATION-INDUCED DISEASE IN DOGS | 1996 |
|
RU2253456C2 |
CATECHOL-O-METHYLTRANSFERASE INHIBITORS AND THEREOF APPLICATION FOR TREATMENT OF PSYCHOTIC DISORDERS | 2011 |
|
RU2563634C2 |
PYRAZOLOPYRIDINE DERIVATIVES AS KINASE INHIBITORS | 2015 |
|
RU2733400C2 |
ISOXAZOLINE DERIVATIVES AS ANTI-PARASITIC AGENTS | 2011 |
|
RU2551354C2 |
NEW COMPOUNDS AND COMPOSITIONS FOR NAMPT INHIBITION | 2011 |
|
RU2617988C2 |
PYRAZOLOPYRIMIDINES AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS | 1993 |
|
RU2124016C1 |
Authors
Dates
2017-02-08—Published
2012-10-26—Filed